Peretz T - Search Results

1

The 21-gene recurrence score assay (Oncotype DX™) in estrogen receptor-positive male breast cancer: experience in an Israeli cohort.

Grenader T, Yerushalmi R, Tokar M, Fried G, Kaufman B, Peretz T, Geffen DB. Grenader T, et al. Among authors: peretz t. Oncology. 2014;87(1):1-6. doi: 10.1159/000360793. Epub 2014 Jun 20. Oncology. 2014. PMID: 24970679

2

Clinical studies of liposome-encapsulated doxorubicin.

Gabizon A, Isacson R, Libson E, Kaufman B, Uziely B, Catane R, Ben-Dor CG, Rabello E, Cass Y, Peretz T, et al. Gabizon A, et al. Among authors: peretz t. Acta Oncol. 1994;33(7):779-86. doi: 10.3109/02841869409083948. Acta Oncol. 1994. PMID: 7993646

3

Ovarian stimulation and breast cancer: is there a link?

Brzezinski A, Peretz T, Mor-Yosef S, Schenker JG. Brzezinski A, et al. Among authors: peretz t. Gynecol Oncol. 1994 Mar;52(3):292-5. doi: 10.1006/gyno.1994.1051. Gynecol Oncol. 1994. PMID: 8157185

4

Multiple parenchymal liver metastases as the first site of recurrent ovarian carcinoma: a case report and review of the literature.

Lyass O, Brufman G, Edelmann DZ, Prus D, Lebensart PD, Peretz T. Lyass O, et al. Among authors: peretz t. Eur J Gynaecol Oncol. 1997;18(1):68-70. Eur J Gynaecol Oncol. 1997. PMID: 9061329

5

CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: results by demographic and clinical subgroups.

Ron IG, Wigler N, Borovik R, Peretz T, Rizel S, Shani A, Brenner J, Farbstein H, Brenner HJ, Chaitchik S, Catane R, Inbar MJ. Ron IG, et al. Among authors: peretz t. Am J Clin Oncol. 2002 Oct;25(5):520-2. doi: 10.1097/00000421-200210000-00020. Am J Clin Oncol. 2002. PMID: 12393997 Clinical Trial.

6

Mucosal melanoma of the female genital tract is a multifocal disorder.

Lotem M, Anteby S, Peretz T, Ingber A, Avinoach I, Prus D. Lotem M, et al. Among authors: peretz t. Gynecol Oncol. 2003 Jan;88(1):45-50. doi: 10.1006/gyno.2002.6848. Gynecol Oncol. 2003. PMID: 12504626

7

Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.

Grenader T, Shavit L, Uziely B, Peretz T. Grenader T, et al. Among authors: peretz t. J Natl Cancer Inst. 2005 Feb 2;97(3):235-6. doi: 10.1093/jnci/dji037. J Natl Cancer Inst. 2005. PMID: 15687369 No abstract available.

8

BRCA1 and BRCA2 germ-line mutations and oral contraceptives: to use or not to use.

Grenader T, Peretz T, Lifchitz M, Shavit L. Grenader T, et al. Among authors: peretz t. Breast. 2005 Aug;14(4):264-8. doi: 10.1016/j.breast.2005.01.005. Breast. 2005. PMID: 16085232 Review.

9

Psychological distress and coping in breast cancer patients and healthy women whose parents survived the Holocaust.

Baider L, Goldzweig G, Ever-Hadani P, Peretz T. Baider L, et al. Among authors: peretz t. Psychooncology. 2006 Jul;15(7):635-46. doi: 10.1002/pon.1010. Psychooncology. 2006. PMID: 16363011

10

[Metastatic testicular cancer presenting with venous thromboembolism].

Grenader T, Gutfeld O, Shavit L, Sella T, Peretz T. Grenader T, et al. Among authors: peretz t. Harefuah. 2006 Jan;145(1):30-1, 78. Harefuah. 2006. PMID: 16450721 Hebrew.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters